Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | P18 - Poster Session 18

Thursday 04/07/22
05:30 PM - 06:30 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Practice, Policy, and Ethics, Aging, Dementia, Cognitive, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Global Health and Neuroepidemiology, Health Care Disparities, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Neuro-rehabilitation
0.00 CME credit
Diversity, Equity, and Inclusion

Program Materials Program Evaluations

Event Timeline
05:30 PM - 06:30 PM PDT Abstract 9-001 - Paraneoplastic Stiff Person Syndrome: Persistence of Symptoms is Common Despite Treatment of Underlying Malignancy
Alexandra Christina Simpson, MD
05:30 PM - 06:30 PM PDT Abstract 9-002 - Powassan Encephalitis: A Case Report from Long Island, New York, USA
Danielle Bazer, DO
05:30 PM - 06:30 PM PDT Abstract 9-003 - Combined central and peripheral demyelination syndrome after COVID-19 vaccination with brisk response to plasma exchange and steroids
William Hoffman, MD
05:30 PM - 06:30 PM PDT Abstract 9-004 - Characterization of Neurological Morbidity Associated with Anti-Thyroid Antibodies: Hashimoto’s Encephalopathy and Beyond
Mark Phillips Figgie, Jr., MD
05:30 PM - 06:30 PM PDT Abstract 9-005 - Autonomic dysfunction following COVID-19 infection: an early experience
Kamal Shouman, MD
05:30 PM - 06:30 PM PDT Abstract 9-006 - Mortality Risk Factors in Patients with Diabetic Autonomic Neuropathy: Insights from a Structured Clinical Documentation Toolkit
Alexandru C. Barboi, MD
05:30 PM - 06:30 PM PDT Abstract 9-007 - Mycoplasma Pneumoniae Infection Associated with Autoimmune Small Fiber Neuropathy and Postural Orthostatic Tachycardia Syndrome (POTS)
Kamal R. Chemali, MD
05:30 PM - 06:30 PM PDT Abstract 15-001 - Accuracy of Automated Analyzers for the Estimation of CSF Cell Counts: A Systematic Review and Meta-Analysis
Greer Waldrop, MD
05:30 PM - 06:30 PM PDT Abstract 15-002 - Authorship Diversity in Cochrane Systematic Reviews of Stroke: Inequities in Global Representation
Vivek Bhat
05:30 PM - 06:30 PM PDT Abstract 15-003 - International COVID-19 Vaccine Experience and Perceptions Survey in Patients with Myasthenia Gravis: An Interim Analysis
Yingkai Li, MD, PhD
05:30 PM - 06:30 PM PDT Abstract 15-004 - Quality of Life in Epilepsy patients in India during Covid-19 pandemic.
Nirmal Surya, MD, DNB, FAAN
05:30 PM - 06:30 PM PDT Abstract 15-005 - Socio-epidemiological Factors associated with the Incidence of Cerebrospinal Meningitis in Sub-Saharan Africa
Gabriel D. Pinilla Monsalve, MD, MSc
05:30 PM - 06:30 PM PDT Abstract 3-001 - Learning to PERSEVERE: Feasibility and Efficacy of Peer Mentor Support and Caregiver Education in Lewy Body Dementia
Jori Fleisher, MD, MSCE, FAAN
05:30 PM - 06:30 PM PDT Abstract 3-002 - Digital Driving Metrics Index Early Mobility Declines in Patients At Risk for Alzheimer’s Disease
Jennifer Merickel
05:30 PM - 06:30 PM PDT Abstract 3-003 - Huntingtin gene intermediate alleles influence the progression from Subjective Cognitive Decline to Mild Cognitive Impairment: a 15-year follow-up study
Salvatore Mazzeo
05:30 PM - 06:30 PM PDT Abstract 3-004 - Combination of Antidepressants and Antipsychotics as Novel Treatment Options for Psychosis in Alzheimer’s Disease
Peihao Fan, MBBS
05:30 PM - 06:30 PM PDT Abstract 3-005 - TRAILBLAZER-ALZ 2: A Phase 3 Study to Assess Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer’s Disease
Jennifer Zimmer, MD
05:30 PM - 06:30 PM PDT Abstract 12-001 - DAMS-Net: A Domain Adaptive Lesion Segmentation Framework in Patients with Multiple Sclerosis from Multiple Imaging Centers
Dongnan Liu, PhD
05:30 PM - 06:30 PM PDT Abstract 12-002 - Social Networks in Pediatric-Onset Multiple Sclerosis are Associated with Less Negative Peer Pressure
Micky Kyler Bacchus
05:30 PM - 06:30 PM PDT Abstract 12-003 - haMSter: a Smartphone Application for Remote Patient Monitoring
Patrick Altmann
05:30 PM - 06:30 PM PDT Abstract 12-004 - Digital Performance Measures Show Sensitivity to Demographic and Disease Characteristics in a Multiple Sclerosis Cohort Utilizing the MS Care Connect Mobile App in a Real-world Setting
Ryan Metzger, PhD
05:30 PM - 06:30 PM PDT Abstract 12-005 - User Perspectives on a Digital Therapeutic for Major Depressive Disorder in Multiple Sclerosis Patients: A Qualitative Study
Gina Kackloudis, Other
05:30 PM - 06:30 PM PDT Abstract 12-006 - Reliability of Mobile Video Oculography in a prospective cohort of MS patients
Mikael Cohen
05:30 PM - 06:30 PM PDT Abstract 12-007 - TELE MS: A Randomized Controlled Trial Investigating Remote Visits in People with Multiple Sclerosis
Patrick Altmann
05:30 PM - 06:30 PM PDT Abstract 12-008 - Use of MyChart Messages and Telephone Calls in Patients with Multiple Sclerosis at an Academic Medical Center
Caralynn Li, DO
05:30 PM - 06:30 PM PDT Abstract 12-009 - Evaluating Telemedicine Care in Patients with Neuroimmunological Disorders via a Questionnaire Based Survey
Huiam Mubarak, MD
05:30 PM - 06:30 PM PDT Abstract 12-010 - Relationship of Superficial White Matter Integrity and Cognition in Early MS: A Machine Learning Study
Korhan Buyukturkoglu, PhD
05:30 PM - 06:30 PM PDT Abstract 6-001 - Pooled Safety Data from the Risdiplam Clinical Trial Development Program
Basil T. Darras, MD
05:30 PM - 06:30 PM PDT Abstract 6-002 - Real-world Outcomes of Nusinersen Alone and Onasemnogene Abeparvovec (OA) Alone or with Prior Nusinersen in Pediatric Patients with Spinal Muscular Atrophy (SMA): Interim Analysis of a US Retrospective Chart Review Study
Omar Dabbous, MD
05:30 PM - 06:30 PM PDT Abstract 6-003 - Baseline Characteristics and Initial Safety Results in RESPOND: A Phase 4 Study of Nusinersen in Children with Spinal Muscular Atrophy (SMA) Who Received Onasemnogene Abeparvovec
John Brandsema, MD
05:30 PM - 06:30 PM PDT Abstract 6-004 - A Rare Case of Congenital Myasthenia Syndrome 11 Caused by a Novel Mutation in RAPSN Diagnosed with Rapid Whole Genome Sequencing (rWGS).
Graham Kiyoshi Reid, DO
05:30 PM - 06:30 PM PDT Abstract 7-001 - Teleintervention for Persisting Symptoms Post-Acute COVID-19 Illness Using Transcranial Direct Current Stimulation (tDCS)
Tehila Eilam-Stock, PhD
05:30 PM - 06:30 PM PDT Abstract 7-002 - Visual Field Defect Rehabilitation through Visual Restoration Therapy
Lakshmanan Sankaranarayanan, Sr.
05:30 PM - 06:30 PM PDT Abstract 7-003 - Treating word finding difficulty in multiple sclerosis using high-definition transcranial direct current stimulation targeting the pre-Supplementary Motor Area
Hsueh-Sheng Chiang, MD, PhD
05:30 PM - 06:30 PM PDT Abstract 7-004 - Application of Principal Component and Discriminant Analyses on Hippocampal Neuromodulation During a Direct Reach Task
Richard Lee
05:30 PM - 06:30 PM PDT Abstract 7-005 - Regaining control of movement following a spinal cord injury using Epidural Electrical Stimulation coupled with Task Specific Training
Srimathy Narasimhan, Other
05:30 PM - 06:30 PM PDT Abstract 7-006 - A Teleintervention Program for Multiple Sclerosis (MS) Mobility: Exercise with Transcranial Direct Current Stimulation (tDCS)
Giuseppina Pilloni, PhD
05:30 PM - 06:30 PM PDT Abstract 1-001 - Patient Satisfaction of Teleneurology during COVID-19 Pandemic in Detroit
Bowen Song, MD
05:30 PM - 06:30 PM PDT Abstract 1-002 - Neurology Resident Burnout and Wellness: A Quality Assessment Inventory Tool
Daniel Minsuk Oh, MD
05:30 PM - 06:30 PM PDT Abstract 1-003 - Improving Seizure Management through Interprofessional Collaboration
Michael Miller Chang, DO
05:30 PM - 06:30 PM PDT Abstract 1-004 - Assessing the DEI needs of an Academic Neurology Department
Sonia Kaur Singh, MD
05:30 PM - 06:30 PM PDT Abstract 10-001 - Effects of an Evidence-Based Continuous EEG Triage Protocol on Seizure Detection in Hospitalized Adults: A Quality Improvement Analysis
Brent Jacobus, II, MD
05:30 PM - 06:30 PM PDT Abstract 10-002 - A Case Report of Second Degree Heart Block and Sinus Pauses after VNS Placement in Refractory Epilepsy
Hongxuyang Yu, MD
05:30 PM - 06:30 PM PDT Abstract 10-003 - Trends in Antiseizure Medication Fills and Cost in Medicare Beneficiaries with Epilepsy
Samuel Waller Terman, MD
05:30 PM - 06:30 PM PDT Abstract 10-004 - How Long is a Piece of String? A Retrospective Study of the Correlation Between Length of Stay in Epilepsy Monitoring Unit and Diagnostic Yield
Mohammad Hijaz Adenan, MBBS
05:30 PM - 06:30 PM PDT Abstract 10-005 - An Online, Interactive, Self-Paced, Case-Based Clinical Neurophysiology Curriculum for Neurology Residents
Valerie Jeanneret Lopez, MD
05:30 PM - 06:30 PM PDT Abstract 10-006 - Petechiae: An Atypical Initial Presentation of Seizure
Shivanee Sodani, MBBS
05:30 PM - 06:30 PM PDT Abstract 10-007 - Serving Los Angeles County Patients with Teleneurology, A Clinical Tool Here to Stay
Bo Carl Leung, MD
05:30 PM - 06:30 PM PDT Abstract 4-001 - Disseminated Cytomegalovirus Infection with Meningoencephalitis in an Immunosuppressed Renal Transplant Patient
Jaspreet Johal, MD
05:30 PM - 06:30 PM PDT Abstract 4-002 - Nocardia Spinal Abscess in the Immunocompetent Patient
Jennifer Hannah Newman, MD
05:30 PM - 06:30 PM PDT Abstract 4-003 - Central Nervous System Tuberculosis with SARS-CoV-2 Infection: A Short Case-series from Sri Lanka
Shanindra Revanka De Alwis, MD, MBBS
05:30 PM - 06:30 PM PDT Abstract 4-004 - To Report A Rare Case of Focal Cranial Nerve and Long Tract Neurologic Deficits associated with Legionnaire's disease
Arshdeep Kaur, MD
05:30 PM - 06:30 PM PDT Abstract 4-005 - Restoring Levels of a Tumor Suppressor to Treat Glioblastoma using an RNA Therapeutic Strategy
Rohan Rao
05:30 PM - 06:30 PM PDT Abstract 13-001 - Feeding tube dependence among older stroke patients with feeding tubes
Corey R. Fehnel, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 13-002 - Association Between Mean Platelet Volume And Severity Of Acute Ischaemic Stroke Assessed By Modified Rankin Scale
Dinesh Mohan Chaudhari, DNB
05:30 PM - 06:30 PM PDT Abstract 13-003 - Closing Gaps in Care of Patients with Embolic Stroke of Unknown Source: A Multi-disciplinary approach
Lamya Ibrahim, MD, MBBS
05:30 PM - 06:30 PM PDT Abstract 13-004 - Acute Pain: A Consideration in Blood Pressure Management in Acute Ischemic Stroke in the Sickle Cell Patient
Joseph Frazee, DO
05:30 PM - 06:30 PM PDT Abstract 13-005 - Pediatric Cerebral Infarction associated with recent SARS-CoV-2 mild infection treated with intravenous thrombolysis and endovascular thrombectomy
Luis Guillermo Manrique, MD
05:30 PM - 06:30 PM PDT Abstract 13-006 - Neuroimaging in COVID-19 Patients on Mechanical Ventilation Receiving Sedation: Insight Beyond Diagnosis
Saman Fatima, MD
05:30 PM - 06:30 PM PDT Abstract 13-007 - Cerebrovascular Manifestations of COVID-19 in Young Adults
Pranusha Pinna, DO
05:30 PM - 06:30 PM PDT Abstract 13-008 - Patterns of Seeking Emergent Stroke Care During the COVID -19 Pandemic: A Nebraska Stroke Center Perspective
Mohammad Dibs, MD
05:30 PM - 06:30 PM PDT Abstract 13-009 - Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic
Jay Liuhong Liu, DO
05:30 PM - 06:30 PM PDT Abstract 13-010 - Acute stroke patients with low NIHSS did not delay hospital presentation during COVID
Ali E. Kaabi, MD
05:30 PM - 06:30 PM PDT Abstract 5-001 - A systematic review of the spectrum and prevalence of non-motor symptoms in adults with progressive cerebellar ataxias
Naveed Malek, MD
05:30 PM - 06:30 PM PDT Abstract 5-002 - Tremor in Spinocerebellar Ataxia 12 (SCA12): Clinical and Electrophysiological Perspective
Achal K. Srivastava, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 5-003 - Acute Cerebellar Ataxia after COVID-19 Infection in a 5-year-old Boy.
Kimberly O'Neill, MD
05:30 PM - 06:30 PM PDT Abstract 5-004 - Unusual Presentation of Self Limiting Neonatal Seizures Along with Other Neurological Manifestations in Siblings Diagnosed with Spinocerebellar Ataxia Type 8 (SCA 8)
Shrikant Mishra, MD, FAAN
05:30 PM - 06:30 PM PDT Abstract 5-005 - Progressive Ataxia and Palatal Tremor with MRI Evidence of Hypertrophic Olivary Degeneration
Jennifer Hislop, MD
05:30 PM - 06:30 PM PDT Abstract 5-006 - Cerebellar Fit in an Adult with Chiari II Malformation
Austin Mefford
05:30 PM - 06:30 PM PDT Abstract 5-007 - Social media consumption in adolescents with tics
Jessica Frey, MD
05:30 PM - 06:30 PM PDT Abstract 5-008 - Functional Tic Disorders in Children during the COVID-19 Pandemic
Marisela E. Dy-Hollins, MD, MSCR, FAAN
05:30 PM - 06:30 PM PDT Abstract 2-001 - The Impact of a Portable Artificial Vision Device (OrCam Read) on Vision-Related Quality-of-Life in Patients with Primary Brain Tumors and Low Vision
Tanvi Chokshi
05:30 PM - 06:30 PM PDT Abstract 2-002 - An Interprofessional Residency Education and Utilization of the Phone-adapted Panoptic Ophthalmoscope
Lauryn Currens, MD
05:30 PM - 06:30 PM PDT Abstract 2-003 - A Sneak into the science of the Sneaker colour- Is it truly related to Cerebral Dominance?
Harini Pavuluri
05:30 PM - 06:30 PM PDT Abstract 2-004 - Association Between COVID-19 Vaccination and Optic Neuritis in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study
Mustafa Jaffry
05:30 PM - 06:30 PM PDT Abstract 2-005 - Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC)
Laura J. Balcer, MD, MSCE, FAAN
05:30 PM - 06:30 PM PDT Abstract 11-001 - Attitudes, Beliefs and Experiences of an Academic Neurology Department Regarding Systemic Racism: University of Kentucky Neurology Residency Study
Thien Nguyen, MD
05:30 PM - 06:30 PM PDT Abstract 11-002 - Trends in Diversity at a Single US Adult Neurology Residency Program
Keiko Aun Fukuda, MD
05:30 PM - 06:30 PM PDT Abstract 11-003 - The Diversity of Graduate Medical Education Leadership in Neurology
Morgan Christina Jordan, DO
05:30 PM - 06:30 PM PDT Abstract 11-004 - Socioeconomic Bias in Ordering Toxicology Screens in Patients with an Acute Stroke
Fady Mousa-Ibrahim, DO
05:30 PM - 06:30 PM PDT Abstract 11-005 - Can You See Me Now?: Understanding Health Outcomes in Telehealth Among Seniors
Christine Petit-Frere
05:30 PM - 06:30 PM PDT Abstract 11-006 - Pediatric Neurology Patient Disparities in Use of and Access to Rapid Telehealth Implementation during the COVID-19 Pandemic
Lindsey Morgan, MD
05:30 PM - 06:30 PM PDT Abstract 11-007 - Reassessing the Geographical Distribution of Neurologists in the United States
Kyra Curtis, MD
05:30 PM - 06:30 PM PDT Abstract 11-008 - Measuring Ambulatory Neurologic Health Disparities with the Axon Registry
Richard T. Benson, MD, PhD, FAAN
05:30 PM - 06:30 PM PDT Abstract 11-009 - Tightening up Acute Stroke Care in the Stroke Belt with Telestroke
Theresa Beth Sevilis, DO, FAAN
Faculty Disclosures
Eduardo E. Benarroch, MD, FAAN Dr. Benarroch has nothing to disclose.
Jose Biller, MD, FAAN, FACP, FAHA Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Paula R. Clemens, MD The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Richard S. Finkel, MD, FAAN Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
John F. Foley, MD, FAAN The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
John Hart, MD The institution of Dr. Hart has received research support from Department of Defense.
Lauren B. Krupp, MD, FAAN Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lerhman. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for medscape. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroLive. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Krupp has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Cleveland Clinic. Dr. Krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MCIC. The institution of Dr. Krupp has received research support from Biogen. The institution of Dr. Krupp has received research support from National Multiple Sclerosis Society. Dr. Krupp has received intellectual property interests from a discovery or technology relating to health care.
Phillip A. Low, MD, FAAN Dr. Low has nothing to disclose.
Shrikant Mishra, MD, FAAN Dr. Mishra has nothing to disclose.
Edward J. Novotny, Jr., MD, FAAN No disclosure on file
Matthew Rizzo, MD, FAAN The institution of Dr. Rizzo has received research support from NIH. Dr. Rizzo has a non-compensated relationship as a Chair with ABC that is relevant to AAN interests or activities.
Michael Joel Schneck, MD, FAAN An immediate family member of Dr. Schneck has received personal compensation for serving as an employee of Cellcarta. Dr. Schneck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HLT Medical. Dr. Schneck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miscellaneous legal firms. Dr. Schneck has stock in Baxter Labs. The institution of Dr. Schneck has received research support from NIH.
William P. Cheshire, Jr., MD, FAAN Dr. Cheshire has received personal compensation in the range of $0-$499 for serving as a Consultant for oxford university press. Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for elsevier. Dr. Cheshire has received research support from Biohaven. Dr. Cheshire has received personal compensation in the range of $0-$499 for serving as a Visiting professor with Trinity International University. Dr. Cheshire has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities.
Panayiotis Mitsias, MD Dr. Mitsias has nothing to disclose.
Anne C. Van Cott, MD, FAAN Dr. Van Cott has nothing to disclose.
Enrico Silvio Bertini, MD Dr. Bertini has received personal compensation for serving as an employee of Bambino Gesu' Children's Resesarch Hospital.
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Julie Anne Parsons, MD Dr. Parsons has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Parsons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenex. The institution of Dr. Parsons has received research support from AveXis. The institution of Dr. Parsons has received research support from Biogen. The institution of Dr. Parsons has received research support from Scholar Rock. The institution of Dr. Parsons has received research support from Biohaven. The institution of Dr. Parsons has received research support from PTC Therapeutics. The institution of Dr. Parsons has received research support from Novartis.
Kathryn J. Swoboda, MD Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.
Katerina Markopoulou, MD, PhD Dr. Markopoulou has nothing to disclose.
Thomas G. Devlin, MD, PhD Dr. Devlin has received personal compensation for serving as an employee of Neuroscience Innovation Foundation. Dr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nova Signal. Dr. Devlin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Devlin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viz,ai. Dr. Devlin has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Neuroscience Innovation Foundation. Dr. Devlin has stock in Nova Signal. Dr. Devlin has stock in Viz.ai. The institution of Dr. Devlin has received research support from Viz.ai. Dr. Devlin has received research support from Nova Signal. Dr. Devlin has received intellectual property interests from a discovery or technology relating to health care.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia. Dr. Balcer has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for North American Neuro-Ophthalmology Society.
Christianne N. Heck, MD Dr. Heck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors/TeleDoc. The institution of Dr. Heck has received research support from Neuropace, Inc.
Paola Sandroni, MD, PhD, FAAN Dr. Sandroni has nothing to disclose.
Robyn J. Wolintz, MD Dr. Wolintz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Wolintz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme.
Pushpendra Nath Renjen, MD Dr. Renjen has nothing to disclose.
Richard T. Benson, MD, PhD, FAAN Dr. Benson has received personal compensation in the range of $100,000-$499,999 for serving as a Federal employee with HHS/NIH.
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Brenda Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Alexandru C. Barboi, MD Dr. Barboi has nothing to disclose.
Brett M. Kissela, MD, FAAN, MS The institution of Dr. Kissela has received research support from NIH/NINDS and NCATS.
Natte Raksadawan, MD Dr. Raksadawan has received research support from Faculty of Medicine, KMITL.
Mark Wainwright, MD, PhD, FAAN Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics.
Kamal R. Chemali, MD Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Chemali has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Chemali has received research support from Sjögren's Foundation. The institution of Dr. Chemali has received research support from NIH.
Laura A. Kalayjian, MD The institution of Dr. Kalayjian has received research support from NIH.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Sandeep Kumar, MD Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Sanjay P. Singh, MD, FAAN Dr. Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LIFE. Dr. Singh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NEURELIS.
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam .
Robert A. Sweet Robert A. Sweet has nothing to disclose.
Wolfgang Singer, MD Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Robert Hyde, PhD Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Bruce Anthony Chase, PhD Dr. Chase has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nebraska Academy of Sciences.
Lyell K. Jones, MD, FAAN Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a member of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Nizar Souayah, MD, FAAN Dr. Souayah has received publishing royalties from a publication relating to health care.
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Leigh Elkins Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Jennifer S. Hui, MD Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Hui has received research support from Roche. The institution of Dr. Hui has received research support from Abbvie. Dr. Hui has received personal compensation in the range of $500-$4,999 for serving as a Roundtable speaker with Medscape .
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Gregory J. Esper, MD, MBA, FAAN Dr. Esper has stock in NeuroOne Medical Technologies, Inc. Dr. Esper has stock in Focused Cryo, Inc. The institution of an immediate family member of Dr. Esper has received research support from Centers for Disease Control. The institution of Dr. Esper has received research support from Health and Human Services Assistant Secretary for Preparedness and Response. An immediate family member of Dr. Esper has received publishing royalties from a publication relating to health care.
Philip De Jager, MD, PhD Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from Biogen. The institution of Dr. De Jager has received research support from puretech.
John H. Sladky, MD, FAAN Dr. Sladky has nothing to disclose.
Nirmal Surya, MD, DNB, FAAN Dr. Surya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB india, Abbot and Esai pharma. Dr. Surya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbot. Dr. Surya has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ESAI pharma. Dr. Surya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Movement disorder society.
Omotola A. Hope, MD Dr. Hope has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Nicole Gonzales, MD The institution of Dr. Gonzales has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Claudia A. Chiriboga, MD, FAAN Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care.
Lee Birnbaum, MD Dr. Birnbaum has nothing to disclose.
Jeremiah M. Scharf, MD, PhD The institution of Dr. Scharf has received research support from the TLC Foundation for Body-Focused Repetitive Behaviors. Dr. Scharf has received personal compensation in the range of $500-$4,999 for serving as a Speaker for a TAA/CDC Family Day Symposium with the Tourette Association of America. Dr. Scharf has a non-compensated relationship as a Scientific Advisory Board Member with the Tourette Association of America that is relevant to AAN interests or activities.
Fritz Leutmezer Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. Fritz Leutmezer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Almirall, Biogen, Celgene, Johnson&Johnson, Novartis, Merck, Roche, Sanofi, Teva-Ratiopharm. The institution of Fritz Leutmezer has received research support from Biogen, Merck, Novartis, Roche.
Becky Schierman Ms. Schierman has nothing to disclose.
Scott Douglas Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Michelle L. Mauermann, MD, FAAN The institution of Dr. Mauermann has received research support from IONIS. The institution of Dr. Mauermann has received research support from Alnylam. Dr. Mauermann has received publishing royalties from a publication relating to health care.
Lakshmi N. Ranganathan, MD, FAAN Dr. Ranganathan has nothing to disclose.
Sarah E. Berini, MD Dr. Berini has nothing to disclose.
Achal K. Srivastava, MD, FAAN Dr. Srivastava has nothing to disclose.
Thomas Alois Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Roberta Frigerio, MD Dr. Frigerio has nothing to disclose.
Maria Mazurkiewicz-Beldzin Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen, . Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Mazurkiewicz Beldzin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Neuroderm. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Cleveland Clinic. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Sarah M. Benish, MD, FAAN Dr. Benish has nothing to disclose.
Rebecca E. Matthews, MD Dr. Matthews has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Matthews has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with Penry Epilepsy Programs.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has nothing to disclose.
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capricor Therapeutics. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catabasis. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. McDonald has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Santhera Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Astellas. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Catabasis. The institution of Dr. McDonald has received research support from Epirium Bio. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from Pfizer. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from NIDILRR. The institution of Dr. McDonald has received research support from Department of Defense. The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Ksenija Gorni Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche.
Michael Kraut No disclosure on file
Sandra P. Reyna, MD Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Jennifer Zimmer, MD Dr. Zimmer has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Zimmer has stock in Eli Lilly & Company.
Brian Callaghan, MD, MS, FAAN Dr. Callaghan has received personal compensation for serving as an employee of University of Michigan. Dr. Callaghan has received personal compensation for serving as an employee of Ann Arbor Veterans Affairs. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Callaghan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medico-legal work. Dr. Callaghan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Callaghan has received research support from American Academy of Neurology. The institution of Dr. Callaghan has received research support from JDRF. The institution of Dr. Callaghan has received research support from NIDDK. Dr. Callaghan has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viracta. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Mark A. Mintun, MD Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Nathalie M. Goemans, MD Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care.
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Dirk Fischer The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG.
Rita Bhatia No disclosure on file
Arjuna Hirantha Fernando, MD, MBBS, MRCP Dr. Fernando has nothing to disclose.
Ioannis Karakis, MD, FAAN Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Glenn Thurston Stebbins, PhD Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Henry Paul Moore, MD Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie . Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC.
James F. Burke, MD Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes.
Jeff Guptill, MD, FAAN Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has stock in argenx.
Maysaa Merhi Basha, MD Dr. Basha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Jeannette Lechner-Scott, MD, PhD, FRACP The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Muruvet Elkay, MD Dr. Elkay has nothing to disclose.
Jeffrey C. McClean, II, MD, FAAN Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with American Academy of Neurology.
George Nune, MD Dr. Nune has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local residental real estate company.
Anjail Sharrief, MD The institution of Dr. Sharrief has received research support from NIH. The institution of Dr. Sharrief has received research support from University of Houston . Dr. Sharrief has a non-compensated relationship as a Consultant with Abbott that is relevant to AAN interests or activities.
Kiran Thakur, MD, FAAN Dr. Thakur has received personal compensation for serving as an employee of World Health Organization. Dr. Thakur has received personal compensation for serving as an employee of Pan American Health Organization. Dr. Thakur has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Delve Bio. The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention. The institution of Dr. Thakur has received research support from National Institute of Health.
Aimee Borazanci, MD No disclosure on file
Amanda Avila, MD Dr. Avila has nothing to disclose.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Corey R. Fehnel, MD, FAAN Dr. Fehnel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XRHealth. The institution of Dr. Fehnel has received research support from National Institute on Aging .
Valentina Bessi Valentina Bessi has nothing to disclose.
Jeremy K. Cutsforth-Gregory, MD, FAAN Dr. Cutsforth-Gregory has received publishing royalties from a publication relating to health care.
Thy Nguyen, MD Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ArgenX. Dr. Nguyen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Nguyen has received publishing royalties from a publication relating to health care.
Rohit Ajay Marawar, MD, FAAN Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Soma Sengupta, MD, PhD, FAAN Dr. Sengupta has received personal compensation in the range of $0-$499 for serving as a Consultant for Novocure. The institution of Dr. Sengupta has received research support from Harold C. Schott Endowment. Dr. Sengupta has received intellectual property interests from a discovery or technology relating to health care.
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Silvia Bagnoli No disclosure on file
Mohammed N. Zaman, DO Dr. Zaman has nothing to disclose.
Kathleen C. Somera-Molina, PhD Dr. Somera-Molina has received personal compensation for serving as an employee of Biogen. Dr. Somera-Molina has received stock or an ownership interest from Biogen.
Laurel Jean Cherian, MD, FAAN The institution of Dr. Cherian has received research support from NIH.
John Brandsema, MD Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fibrogen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of an immediate family member of Dr. Brandsema has received research support from Argenx. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock.
Wendy Sulina Vargas, MD Dr. Vargas has received personal compensation for serving as an employee of Sanofi. The institution of Dr. Vargas has received research support from NICHD.
Anneke Van Der Walt, MD Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Van Der Walt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Van Der Walt has received research support from NHMRC Australia. The institution of Dr. Van Der Walt has received research support from MSRA. The institution of Dr. Van Der Walt has received research support from Roche.
Kate Daniello, MD, FAAN Dr. Daniello has nothing to disclose.
Jori Fleisher, MD, MSCE, FAAN The institution of Dr. Fleisher has received research support from Parkinson's Foundation. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NINDS. The institution of Dr. Fleisher has received research support from NIH/NIA/Emory Roybal Center for Dementia Caregiving Mastery. Dr. Fleisher has received publishing royalties from a publication relating to health care. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Parkinson's Foundation. Dr. Fleisher has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lewy Body Dementia Association. Dr. Fleisher has received personal compensation in the range of $0-$499 for serving as a Speaker with Davis Phinney Foundation. Dr. Fleisher has a non-compensated relationship as a Editorial Board Member with AAN Brain & Life Magazine that is relevant to AAN interests or activities.
Shawna W. Benard, MD Dr. Benard has nothing to disclose.
Mikael Cohen Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Nicholas Deconinck Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for avexis. Nicholas Deconinck has received publishing royalties from a publication relating to health care.
Eugenio Mercuri Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis, Scholar Rock, Cytokinetics. Eugenio Mercuri has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sarepta, Santhera, PTC, Pfizer, Roche, Biogen, Avexis Novartis. The institution of Eugenio Mercuri has received research support from biogen.
James F. Sumowski Mr. Sumowski has nothing to disclose.
Elizabeth A. Coon, MD, FAAN Dr. Coon has nothing to disclose.
Fawaz Al-Mufti, MD Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Laura J. Wu, MD, PhD Dr. Wu has nothing to disclose.
Heidi N. Beadnall, MD Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Beadnall has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Beadnall has received research support from MSBase Foundation.
Ivan Da Silva, MD Dr. Da Silva has nothing to disclose.
Marisela E. Dy-Hollins, MD, MSCR, FAAN The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Paulus Stefan Rommer Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Hesham Ahmed Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Katherine Buzzard, PhD, FRACP, MBBS Dr. Buzzard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Buzzard has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Buzzard has received personal compensation in the range of $5,000-$9,999 for serving as a support to attend educational conference with Roche.
Ram Mohan R. Sankaraneni, MD, FANA, FAES, FAAN Dr. Sankaraneni has nothing to disclose.
Victoria Leavitt, PhD, FAAN Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Michael Owen Kinney, MD Dr. Kinney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle Therapeutics .
Ajay M. Tunguturi, MD Dr. Tunguturi has nothing to disclose.
Chantale Octavia Branson, MD, FAAN Dr. Branson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus.
Yujie Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech.
Tzu-ying Chuang, MD, PhD Dr. Chuang has nothing to disclose.
Alejandro Vargas, MD, MS Dr. Vargas has nothing to disclose.
Arif A. Shukralla, MD Dr. Shukralla has nothing to disclose.
Guillaume Lamotte, MD Dr. Lamotte has nothing to disclose.
Hsueh-Sheng Chiang, MD, PhD The institution of Dr. Chiang has received research support from NIH/NIDCD. The institution of Dr. Chiang has received research support from Texas Alzheimer's Research and Care Consortium.
Lindsey Morgan, MD The institution of Dr. Morgan has received research support from NIH. The institution of Dr. Morgan has received research support from PERF.
Theresa Beth Sevilis, DO, FAAN Dr. Sevilis has stock in Moderna.
Tammy Thu Ann Pham, MD Dr. Pham has nothing to disclose.
Erika Tatiana Marulanda-Londono, MD Dr. Marulanda-Londono has nothing to disclose.
Adalia H. Jun-O'Connell, MD, MBA Dr. Jun-O'Connell has nothing to disclose.
Monica B. Dhakar, MBBS The institution of Dr. Dhakar has received research support from NIH. The institution of Dr. Dhakar has received research support from UCB Biopharma. The institution of Dr. Dhakar has received research support from Marinus Pharmaceuticals.
Ajitesh Ojha, MD Dr. Ojha has nothing to disclose.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Michele Faulkner, PharmD Michele Faulkner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Michele Faulkner has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cullan and Cullan. Michele Faulkner has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Johnson, Tabor & Johnson.
Keiko Aun Fukuda, MD Dr. Fukuda has nothing to disclose.
Amy Kuceyeski, PhD An immediate family member of Dr. Kuceyeski has received personal compensation for serving as an employee of Heyer Physical Therapy. The institution of Dr. Kuceyeski has received research support from National Institutes of Health. Dr. Kuceyeski has received personal compensation in the range of $500-$4,999 for serving as a Grant Panel Member with Department of Defense.
Ming Lu Ming Lu has received personal compensation for serving as an employee of Eli Lilly and Company. Ming Lu has received stock or an ownership interest from Eli Lilly and Company.
Ram Narendra Narayan, MD Dr. Narayan has nothing to disclose.
Bichum Ouyang The institution of Bichum Ouyang has received research support from NIH.
Senaka Bandusena, MD, MBBS, FCCP Dr. Bandusena has nothing to disclose.
Julian Thomas, MD Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Michael *use 103839 Barnett, MBBS Michael Barnett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sydney Neuroimaging Analysis Centre. An immediate family member of Michael Barnett has received stock or an ownership interest from RxMx. The institution of Michael Barnett has received research support from Genzyme Sanofi. The institution of Michael Barnett has received research support from Biogen. The institution of Michael Barnett has received research support from Novartis.
Bruce Taylor Bruce Taylor has nothing to disclose.
Jonathan Kuo, MD Dr. Kuo has nothing to disclose.
Seth Nathatn Levin, MD Dr. Levin has received personal compensation for serving as an employee of Biogen. Dr. Levin has received stock or an ownership interest from Biogen.
Nicole Rosendale, MD Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. The institution of Dr. Rosendale has received research support from American Academy of Neurology. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Kiran M. Kanth, MD Dr. Kanth has nothing to disclose.
Ayaz M. Khawaja, MD Dr. Khawaja has nothing to disclose.
Eric J. Seachrist, MD Dr. Seachrist has stock in Medtronic. Dr. Seachrist has stock in Pfizer. The institution of Dr. Seachrist has received research support from Bristol Myers Squibb. Dr. Seachrist has a non-compensated relationship as a Topic Group, QOD Committee, and Wellness Program Committee with American Academy of Neurology that is relevant to AAN interests or activities.
Payal B. Patel, MD The institution of Dr. Patel has received research support from National Institute of Health. Dr. Patel has received personal compensation in the range of $0-$499 for serving as a Author with MedLink Neurology.
Amna Sohail, MD Dr. Sohail has nothing to disclose.
Khawla M. Abusamra, MBBS Dr. Abusamra has nothing to disclose.
Melissa Gresle The institution of Melissa Gresle has received research support from Biogen International. The institution of Melissa Gresle has received research support from F Hoffman La Roche. The institution of Melissa Gresle has received research support from Roche Australia.
Naveed Malek, MD Dr. Malek has nothing to disclose.
Tomas Kalincik Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Alexandra Christina Simpson, MD Dr. Simpson has nothing to disclose.
Padma Vasantha Hadakasira, MD Dr. Hadakasira has nothing to disclose.
Carlos Guevara Oliva, MD Dr. Guevara Oliva has nothing to disclose.
Yin Allison Liu, MD Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Liu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Trishna Kantamneni, MBBS Dr. Kantamneni has nothing to disclose.
Nataliya Pyatka, MD Dr. Pyatka has nothing to disclose.
Kamal Shouman, MD The institution of Dr. Shouman has received research support from dysautonomia international.
Tracy Tholanikunnel, MD Dr. Tholanikunnel has nothing to disclose.
Deepak N. Reddy, MD Dr. Reddy has nothing to disclose.
Ima M. Ebong, MD The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
Aparna Polavarapu Ramarao, MD Dr. Polavarapu Ramarao has nothing to disclose.
Katherine Park, MD Dr. Park has nothing to disclose.
Olga Syritsyna, MD The institution of Dr. Syritsyna has received research support from NeuroNext.
Jennifer Hislop, MD Dr. Hislop has nothing to disclose.
Lisena Hasanaj Ms. Hasanaj has nothing to disclose.
Ryan Metzger, PhD An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Mariana Suarez Mariana Suarez has nothing to disclose.
Venugopalan Y Vishnu, MD The institution of Dr. Vishnu has received research support from Department of Health Research.
Shankar Balakrishnan, MBBS No disclosure on file
Chenyu Wang Chenyu Wang, 7886 has received personal compensation for serving as an employee of Sydney Neuroimaging Analysis Centre. The institution of Chenyu Wang, 7886 has received research support from Multiple Sclerosis Research Australia.
Janaki Patel, MD Dr. Patel has nothing to disclose.
Angelene Christensen Ms. Christensen has a non-compensated relationship as a project manager with InterPro Bioscience that is relevant to AAN interests or activities.
Norman Delanty, MD No disclosure on file
Karen Lundgren Ms. Lundgren has nothing to disclose.
Denise Fay Chen Ms. Chen has nothing to disclose.
Kallol Kumar Set, MD Dr. Set has nothing to disclose.
Amy Armstrong-Javors, MD Dr. Armstrong-Javors has nothing to disclose.
Gabriel Bsteh, MD Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene-BMS. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Bsteh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme.
Swetha Ade, MD Dr. Ade has nothing to disclose.
Samuel Waller Terman, MD Dr. Terman has received research support from American Epilepsy Society. Dr. Terman has received research support from Epilepsy Study Consortium. Dr. Terman has received research support from New York University. Dr. Terman has received personal compensation in the range of $100,000-$499,999 for serving as a clinician scientist trainee for Susan S Spencer award with American Academy of Neurology.
Prashant Kumar Rai, MD Dr. Rai has nothing to disclose.
Pranusha Pinna, DO Dr. Pinna has nothing to disclose.
Michael Vincent Robers, MD Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Robers has received research support from National Multiple Sclerosis Society. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Robers has received research support from Barrow Neurological Foundation.
Spencer Hutto, MD Dr. Hutto has nothing to disclose.
Bo Carl Leung, MD Dr. Leung has nothing to disclose.
Zahari Tchopev, MD Dr. Tchopev has nothing to disclose.
Shashwat Pokharel, MBBS Dr. Pokharel has nothing to disclose.
Muhammad Athar Muhammad Athar has nothing to disclose.
Julia Kofler The institution of Julia Kofler has received research support from NIH.
Linda Ly Linda Ly has nothing to disclose.
Guhan Ramamurthy, MD, DM Dr. Ramamurthy has nothing to disclose.
Roopa Rajan Roopa Rajan has received research support from DBT. Roopa Rajan has received research support from DST-SERB. The institution of Roopa Rajan has received research support from Michael J Fox Foundaton.
Joshua Chodosh, MD The institution of Dr. Chodosh has received research support from NIH-NIA. The institution of Dr. Chodosh has received research support from NIH-NIMHD. The institution of Dr. Chodosh has received research support from NIH-NINR. The institution of Dr. Chodosh has received research support from SCAN Health Plan. The institution of Dr. Chodosh has received research support from New York State Department of Health.
Mathura Ravishankar, MD Dr. Ravishankar has nothing to disclose.
Morgan Christina Jordan, DO Dr. Jordan has nothing to disclose.
Milena Lobaina, MD Dr. Lobaina has nothing to disclose.
Agnelio Silverio Cardentey, MD Dr. Cardentey has nothing to disclose.
Harshad Ladha, MD Dr. Ladha has nothing to disclose.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Ruba Al-Ramadhani, MD Dr. Al-Ramadhani has nothing to disclose.
Gabriel D. Pinilla Monsalve, MD, MSc Dr. Pinilla Monsalve has nothing to disclose.
Jon Alexander Karel, Md Dr. Karel has nothing to disclose.
Gabriela Trifan, MD Dr. Trifan has nothing to disclose.
Sabeena Iqbal Malik, MD Dr. Malik has nothing to disclose.
Alexandra Rose Balshi Ms. Balshi has nothing to disclose.
Min Yang Min Yang has nothing to disclose.
Therese Dunne, MD Dr. Dunne has nothing to disclose.
Shaweta Khosa, MD Dr. Khosa has nothing to disclose.
Giulia Giacomucci Ms. Giacomucci has nothing to disclose.
Ashalatha Radhakrishnan, Sr., MD Dr. Radhakrishnan has nothing to disclose.
Jee-young Han, MD Dr. Han has nothing to disclose.
Colleen Louise Schneider Ms. Schneider has nothing to disclose.
Negar Moheb, MD Dr. Moheb has nothing to disclose.
Joanne M. Wagner, PhD, PT Dr. Wagner has received personal compensation for serving as an employee of Xenon Pharmaceuticals. Dr. Wagner has received personal compensation for serving as an employee of Biogen. Dr. Wagner has stock in Biogen. Dr. Wagner has stock in Xenon Pharmaceuticals.
Huiam Mubarak, MD Dr. Mubarak has nothing to disclose.
Valerie Jeanneret Lopez, MD Dr. Jeanneret Lopez has nothing to disclose.
Mark Phillips Figgie, Jr., MD Dr. Figgie has nothing to disclose.
Keval D. Shah, MD Dr. Shah has nothing to disclose.
Serena Hess Serena Hess has nothing to disclose.
Munachi Nkiru Okpala, NP Ms. Okpala has nothing to disclose.
Jay Liuhong Liu, DO Dr. Liu has nothing to disclose.
Muhammad Bilal Tariq, MBBS Dr. Tariq has nothing to disclose.
Korhan Buyukturkoglu, PhD Dr. Buyukturkoglu has nothing to disclose.
Sujani Bandela, MD Dr. Bandela has nothing to disclose.
Greer Waldrop, MD Dr. Waldrop has nothing to disclose.
William Hoffman, MD The institution of Dr. Hoffman has received research support from United States Air Force. Dr. Hoffman has a non-compensated relationship as a Member with United States Air Force that is relevant to AAN interests or activities.
Daniel Minsuk Oh, MD Dr. Oh has nothing to disclose.
Angela Aungst Angela Aungst has nothing to disclose.
Birgit Jaber Birgit Jaber has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Birgit Jaber has received stock or an ownership interest from F. Hoffmann-La Roche Ltd. Birgit Jaber has received personal compensation in the range of $100,000-$499,999 for serving as a Senior Safety Director with F. Hoffmann-La Roche Ltd.
Camilla Ferrari Camilla Ferrari has nothing to disclose.
Catherine Yim Catherine Yim has nothing to disclose.
Dinesh Mohan Chaudhari, DNB Dr. Chaudhari has nothing to disclose.
Mohammed Faruq Mohammed Faruq has nothing to disclose.
Francis Cloran, MD Dr. Cloran has nothing to disclose.
Maria Gonzalez-Velez Maria Gonzalez-Velez has nothing to disclose.
Peyton Meyer No disclosure on file
Silvia Bader-Weder, MD Dr. Bader-Weder has received personal compensation for serving as an employee of F. Hoffmann - La Roche. Dr. Bader-Weder has received stock or an ownership interest from F. Hoffmann - La Roche.
Janbernd Kirschner Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genethon. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Italfarmaco. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Janbernd Kirschner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. The institution of Janbernd Kirschner has received research support from Roche. The institution of Janbernd Kirschner has received research support from Biogen. The institution of Janbernd Kirschner has received research support from Novartis.
Yingkai Li, MD, PhD Dr. Li has nothing to disclose.
Tammy McIver Tammy McIver has received personal compensation for serving as an employee of Roche. Tammy McIver has received stock or an ownership interest from Roche .
Kaho Onomichi Kaho Onomichi has nothing to disclose.
Anjali Mishra Anjali Mishra has nothing to disclose.
Lauryn Currens, MD Dr. Currens has nothing to disclose.
Yingying Liu Yingying Liu has received personal compensation for serving as an employee of Biogen. Yingying Liu has received stock or an ownership interest from Biogen.
Allan George Mr. George has nothing to disclose.
Maryam Jamil Syed, MBBS Dr. Syed has nothing to disclose.
Jaspreet Johal, MD Dr. Johal has nothing to disclose.
Josh Bilello Josh Bilello has nothing to disclose.
Matthew Lustberg Matthew Lustberg has nothing to disclose.
Sama Elrahi, MD Ms. Elrahi has nothing to disclose.
Salvatore Mazzeo Mr. Mazzeo has nothing to disclose.
Shahar Shelly, MD Dr. Shelly has nothing to disclose.
Tehila Eilam-Stock, PhD Dr. Eilam-Stock has nothing to disclose.
Andrea Klein Andrea Klein has nothing to disclose.
Ricardo Masson Ricardo Masson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche, Biogen, Avexis. Ricardo Masson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Biogen, Avexis.
Tejas Ranade, MD Dr. Ranade has nothing to disclose.
Luis Guillermo Manrique, MD Dr. Manrique has nothing to disclose.
Anusha Mangalampalli, MD Dr. Mangalampalli has nothing to disclose.
Ramiro Gabriel Castro Apolo, MD Dr. Castro Apolo has nothing to disclose.
Michael Miller Chang, DO Dr. Chang has nothing to disclose.
Ronald Alvarado Dyer, MD Dr. Alvarado Dyer has nothing to disclose.
Patricia Lee, MD Dr. Lee has nothing to disclose.
Hasnain Arshad, MD Dr. Arshad has nothing to disclose.
Giuseppina Pilloni, PhD Dr. Pilloni has nothing to disclose.
Timothy James Ainger, PhD Dr. Ainger has nothing to disclose.
Mashina Chomba, MBChB Dr. Chomba has nothing to disclose.
Elizbieta Wirkowski No disclosure on file
Chun Chieh Lin, PhD The institution of Chun Chieh Lin has received research support from AAN.
Kevin Polet Kevin Polet has nothing to disclose.
Solange Hesse Solange Hesse has nothing to disclose.
Alain Pesce Alain Pesce has nothing to disclose.
Jennifer Merickel Jennifer Merickel has nothing to disclose.
Angela Paradis Angela Paradis has received personal compensation for serving as an employee of Biogen. An immediate family member of Angela Paradis has received personal compensation for serving as an employee of Biogen. Angela Paradis has received stock or an ownership interest from Biogen. An immediate family member of Angela Paradis has received stock or an ownership interest from Biogen.
Sonia Padiglioni Sonia Padiglioni has nothing to disclose.
Badria Munir, MD Dr. Munir has nothing to disclose.
Ahmad Ozair Mr. Ozair has nothing to disclose.
Giovanni Baranello Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Giovanni Baranello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AveXis. The institution of Giovanni Baranello has received research support from Great Ormond Street Hospital Charity.
Micky Kyler Bacchus Miss Bacchus has nothing to disclose.
Patrick Altmann The institution of Mr. Altmann has received research support from Quanterix. The institution of Mr. Altmann has received research support from Biogen, Merck, Roche, Sanofi, Teva,. Mr. Altmann has received intellectual property interests from a discovery or technology relating to health care.
Hany El-Naggar, MD, MBBS, MRCP Dr. El-Naggar has nothing to disclose.
Jennifer Hannah Newman, MD Dr. Newman has nothing to disclose.
Mohammad Jamil Ahmad, MD Dr. Ahmad has nothing to disclose.
Lamya Ibrahim, MD, MBBS Dr. Ibrahim has nothing to disclose.
Sonia Kaur Singh, MD Dr. Singh has nothing to disclose.
Caralynn Li, DO Dr. Li has nothing to disclose.
Brent Jacobus, II, MD Dr. Jacobus has nothing to disclose.
Farman Ali, MD Dr. Ali has nothing to disclose.
Vivek Bhat Mr. Bhat has nothing to disclose.
Danielle Bazer, DO Dr. Bazer has nothing to disclose.
Nicholas Koroneos, DO Dr. Koroneos has nothing to disclose.
Matthew Orwitz, MD Dr. Orwitz has nothing to disclose.
Fady Mousa-Ibrahim, DO Dr. Mousa-Ibrahim has nothing to disclose.
Aaisha Mozumder, MD Dr. Mozumder has nothing to disclose.
Ali E. Kaabi, MD Dr. Kaabi has nothing to disclose.
Kimberly O'Neill, MD Dr. O'Neill has nothing to disclose.
Mohammad Dibs, MD Dr. Dibs has nothing to disclose.
Thien Nguyen, MD Dr. Nguyen has nothing to disclose.
Amin Marji, MD Dr. Marji has nothing to disclose.
Goun Je, MD, PhD Dr. Je has nothing to disclose.
Lakshmanan Sankaranarayanan, Sr. Mr. Sankaranarayanan has nothing to disclose.
Musab Zorlu, MD Dr. Zorlu has nothing to disclose.
Kyra Curtis, MD Ms. Curtis has nothing to disclose.
Hasmik Amirjanyan, MD Dr. Amirjanyan has nothing to disclose.
Christopher Richardson Mr. Richardson has nothing to disclose.
Peihao Fan, MBBS Mr. Fan has nothing to disclose.
Sherline Sauveur, NP Mrs. Sauveur has received personal compensation for serving as an employee of Morehouse School of Medicine.
Konrad Kubicki, MD Dr. Kubicki has nothing to disclose.
Alexandria Cummuta Ms. Cummuta has nothing to disclose.
Shivanee Sodani, MBBS Dr. Sodani has nothing to disclose.
Hongxuyang Yu, MD Dr. Yu has nothing to disclose.
Graham Kiyoshi Reid, DO Dr. Reid has nothing to disclose.
Harini Pavuluri Harini Pavuluri has nothing to disclose.
Ayush Agarwal, DM Dr. Agarwal has nothing to disclose.
Charchit Gupta, DNB No disclosure on file
Arshdeep Kaur, MD Dr. Kaur has nothing to disclose.
Lirong Wang The institution of Lirong Wang has received research support from NIH.
Christine Petit-Frere Ms. Petit-Frere has nothing to disclose.
Mohammad Hijaz Adenan, MBBS Dr. Adenan has nothing to disclose.
Melissa Levin Melissa Levin has nothing to disclose.
Kain Kyle Kain Kyle has received personal compensation for serving as an employee of Sydney Neuroimaging Analysis Centre. Kain Kyle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sydney Neuroimaging Analysis Centre.
Christopher Vergara Christopher Vergara has received research support from ANID-FONDECYT 1190701.
Pamela Guevara Pamela Guevara has received research support from ANID-FONDECYT 1190701. Pamela Guevara has received research support from ANID-BASAL Project FB0008. Pamela Guevara has received research support from ANID-PIA/Anillo de Investigación en Ciencia y Tecnología ACT172121.
Ceren Tozlu Ceren Tozlu has nothing to disclose.
Jacob Dahan Jacob Dahan has nothing to disclose.
Mihaela Georgieva Mihaela Georgieva has nothing to disclose.
Valentina Fuentealba Valentina Fuentealba has received research support from ANID-FONDECYT 1190701.
Sylwia Pocica Sylwia Pocica has nothing to disclose.
Markus Ponleitner Markus Ponleitner has nothing to disclose.
Ranganatha Sitaram Ranganatha Sitaram has nothing to disclose.
Zdenek Berger Zdenek Berger has received personal compensation for serving as an employee of Biogen. Zdenek Berger has received personal compensation for serving as an employee of Pfizer. An immediate family member of Zdenek Berger has received personal compensation for serving as an employee of Sanofi. An immediate family member of Zdenek Berger has received stock or an ownership interest from Sanofi. Zdenek Berger has received stock or an ownership interest from Biogen.
Danielle Obando Danielle Obando has nothing to disclose.
Clara Chu Ms. Chu has nothing to disclose.
Corinne Makepeace Corinne Makepeace has nothing to disclose.
Tobias Monschein Tobias Monschein has nothing to disclose.
Carla Kim Carla Kim has nothing to disclose.
Shiran Ajith Paranavitane, MD, MBBS Dr. Paranavitane has nothing to disclose.
Anish Patel Anish Patel has nothing to disclose.
Yi *Use 386160 Wang Yi Wang has nothing to disclose.
Nicole *USE ID 202625 LaMarca Nicole Marie LaMarca has received personal compensation for serving as an employee of Novartis Gene Therapies.
Renata Scalco Renata SCALCO has received personal compensation for serving as an employee of Roche. Renata SCALCO has received stock or an ownership interest from Roche.
Yaqub Al Sami, MBBS Dr. Al Sami has nothing to disclose.
Sudheer Pachipala Sudheer Pachipala has nothing to disclose.
Amanda Lien Amanda Lien has received personal compensation for serving as an employee of Verana Health. Amanda Lien has stock in Verana Health.
John Jay Alexander, MD Dr. Alexander has nothing to disclose.
Minhwan Kim, MD Mr. Kim has nothing to disclose.
Jingyang Chen Mr. Chen has nothing to disclose.
Rohan Rao The institution of Mr. Rao has received research support from American Brain Tumor Association. The institution of Mr. Rao has received research support from American Academy of Neurology.
Emily Casaletto Miss Casaletto has nothing to disclose.
Aristotle Mante Aristotle Mante has nothing to disclose.
Kai Sheng Loh, MBBS Dr. Loh has nothing to disclose.
Bowen Song, MD Mr. Song has nothing to disclose.
Joseph Frazee, DO Dr. Frazee has nothing to disclose.
Shanindra Revanka De Alwis, MD, MBBS Dr. De Alwis has nothing to disclose.
Hannah Marie Kelly Ms. Kelly has nothing to disclose.
Ukkrit Jansri, PT Mr. Jansri has nothing to disclose.
Nishanth R. Subash Mr. Subash has nothing to disclose.
Dongnan Liu, PhD Dr. Liu has nothing to disclose.
Gregory Wayne Heath, PhD Dr. Heath has received personal compensation in the range of $0-$499 for serving as a Epidemiologic analysis consultant with Neuroscience Innovation Foundation .
Mark *USE ID 212437 McDonald, MD Dr. McDonald has nothing to disclose.
Rachel Supinger, Other Mrs. Supinger has nothing to disclose.
Apostolos Psychogios, MD,Other Dr. Psychogios has nothing to disclose.
Andrew Steckl, PhD The institution of Prof. Steckl has received research support from Procter & Gamble Co.. The institution of Prof. Steckl has received research support from National Institute of Health. Prof. Steckl has received intellectual property interests from a discovery or technology relating to health care.
Jingchu Huang, PhD The institution of Mr. Huang has received research support from P&G.
Daniel Pomeranz Krummel, PhD Prof. Pomeranz Krummel has received stock or an ownership interest from Amlal Pharmaceuticals. An immediate family member of Prof. Pomeranz Krummel has received stock or an ownership interest from Amlal Pharmaceuticals. The institution of an immediate family member of Prof. Pomeranz Krummel has received research support from University of Cincinnati. Prof. Pomeranz Krummel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Prof. Pomeranz Krummel has received intellectual property interests from a discovery or technology relating to health care.
Shreyas Bellur, MBBS Dr. Bellur has nothing to disclose.
Daewoo Han, PhD Dr. HAN has nothing to disclose.
Tanvi Chokshi Miss Chokshi has nothing to disclose.
Jun Ha Chang, PhD Dr. Chang has nothing to disclose.
Debanjan Bhattacharya, PhD Dr. Bhattacharya has nothing to disclose.
Walter *Use 337891 Toro Jimenez, MD,PhD Dr. Toro Jimenez has received personal compensation for serving as an employee of Novartis Gene Therapies, Inc.. Dr. Toro Jimenez has received personal compensation for serving as an employee of Astellas. Dr. Toro Jimenez has stock in Novartis.
Aram Aslanyan Dr. Aslanyan has nothing to disclose.
Rajith Nilantha De Silva, MD Dr. DE SILVA has nothing to disclose.
Omar Dabbous, MD Dr. Dabbous has received personal compensation for serving as an employee of NOVARTIS GENE THERAPIES, INC.. Dr. Dabbous has stock in NOVARTIS GENE THERAPIES, INC.
Donatien Kamdem Toukam, PhD Dr. Kamdem Toukam has nothing to disclose.
Christopher Carley, Other Mr. Carley has received personal compensation for serving as an employee of Analysis Group.
Mustafa Jaffry Mr. Jaffry has nothing to disclose.
Vittoria Conti, MD Miss Conti has nothing to disclose.
Silvia Bagnoli, PhD Dr. Bagnoli has nothing to disclose.
Assunta Ingannato Dr. Ingannato has nothing to disclose.
Filippo Emiliani, MD Dr. Emiliani has nothing to disclose.
Kamel Jedidi, PhD Prof. Jedidi has nothing to disclose.
Eliane Boucher, PhD Ms. Boucher has received personal compensation for serving as an employee of Happify Health. Ms. Boucher has received stock or an ownership interest from Happify Health.
Faizan Akram Mr. Akram has nothing to disclose.
Kranthi Kiran Mandava Mr. Mandava has nothing to disclose.
Alena Makarova, MD Dr. Makarova has nothing to disclose.
Saman Fatima, MD Dr. Fatima has nothing to disclose.
Kelly Davis Garrett, PhD Dr. Garrett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for InterPRO Bioscience.
Mariano Cabezas, PhD Dr. Cabezas has nothing to disclose.
Weidong Cai, PhD Prof. Cai has nothing to disclose.
Sven Vanneste, PhD Prof. Vanneste has nothing to disclose.
Geng Zhan, Other Mr. Zhan has nothing to disclose.
Caio Marconato Matias, MD,PhD Dr. Matias has nothing to disclose.
Acacia C. Parks, PhD Dr. Parks has received personal compensation for serving as an employee of Happify Health. Dr. Parks has received stock or an ownership interest from Happify Health. Dr. Parks has received intellectual property interests from a discovery or technology relating to health care.
Michael Glendinning Mr. Glendinning has nothing to disclose.
Sanjana Rosario Ms. Rosario has nothing to disclose.
Michelle HS Tosin, PhD, RN Dr. Tosin has nothing to disclose.
Danielle Dodson, Other Ms. Dodson has nothing to disclose.
Julie Fratantoni, PhD Dr. Fratantoni has nothing to disclose.
Ruiqian Wu Mr. Wu has nothing to disclose.
Greg S. Vanichkachorn, MD Dr. Vanichkachorn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brain FX. Dr. Vanichkachorn has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanichkachorn has received personal compensation in the range of $0-$499 for serving as a Speaker with Mayo Clinc.
Ying Zhang, PhD The institution of Prof. Zhang has received research support from National Institute of Health. Prof. Zhang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Nationwide Children Hospital.
Marilyn Moffat, PT Dr. Moffat has nothing to disclose.
Sylvia Bowditch, Jr., MD Dr. Bowditch has nothing to disclose.
Srimathy Narasimhan, Other Ms. NARASIMHAN has nothing to disclose.
Richard Lee Mr. Lee has nothing to disclose.
Austin Mefford Mr. Mefford has nothing to disclose.
Jairo Alonso Quiñones, PhD Dr. Quiñones has nothing to disclose.
Tabitha Karatz Ms. Karatz has nothing to disclose.
Natalia Llanos Leyton, Jr., MD Miss Llanos Leyton has nothing to disclose.
Roberto Martin Del Campo Vera, PhD Dr. Martin Del Campo Vera has nothing to disclose.
Yelim Lee Ms. Lee has nothing to disclose.
Gurveer Singh Khosa, MBBS Dr. Khosa has nothing to disclose.
Julie Lima, PhD The institution of Dr. Lima has received research support from National Institute on Aging. The institution of Dr. Lima has received research support from Agency for Healthcare Research and Quality. Dr. Lima has received personal compensation in the range of $500-$4,999 for serving as a Consultant with National Council on Radiation Protection and Measurements.
Manpreet Kaur Kaur Narang, PhD Dr. Narang has nothing to disclose.
Marie Smithgall, MD Dr. Smithgall has nothing to disclose.
Evan Realbuto, Other Mr. Realbuto has nothing to disclose.
Lisa Eller, RN Mrs. Eller has nothing to disclose.
Gina Kackloudis, Other Ms. Kackloudis has received personal compensation for serving as an employee of Happify Health.
Kendra Schomer, Other Dr. Schomer has nothing to disclose.
Steven Kaai Kauwe, PhD Dr. Kauwe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IONIQ Sciences.
Caroline Wang, MD Dr. Wang has nothing to disclose.
Bridget J. Perry, PhD The institution of Dr. Perry has received research support from National Institute of Health. The institution of Dr. Perry has received research support from Massachusetts General Hospital Collaborative Center for XDP.
Daniel Aquino, RN Mr. Aquino has nothing to disclose.
Spencer Kellis, PhD Mr. Kellis has received personal compensation for serving as an employee of Blackrock Neurotech.
Heather Simpson, Other Dr. Simpson has received personal compensation for serving as an employee of Tourette Association of America. Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tourette Association of America.
Carissa Reis, RN Mrs. Reis has nothing to disclose.
Teddy G. Goetz, MD,Other Dr. Goetz has nothing to disclose.
Yi Shen, MD Dr. Shen has nothing to disclose.
Matthew T. Roe, MD Dr. Roe has received personal compensation for serving as an employee of Verana Health. Dr. Roe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Roe has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Roe has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche-Genetech. Dr. Roe has received stock or an ownership interest from Verana Health.
Richard Church, MD Dr. Church has nothing to disclose.
Dongang Wang Mr. Wang has received personal compensation for serving as an employee of Sydney Neuroimaging Analysis Centre.
Roumelia Decontreaus, RN Mrs. Decontreaus has nothing to disclose.
Francisco De la Serna, MD Dr. De la Serna has nothing to disclose.
Andrew Sandefer, DO Dr. Sandefer has nothing to disclose.
Rinu Sebastian, Other Miss Sebastian has nothing to disclose.
Kuang-Hsuan Chen, PhD Prof. Chen has nothing to disclose.
Brian Lee, MD Dr. Lee has nothing to disclose.
Kaitlyn Cocuzzo, Other Miss Cocuzzo has nothing to disclose.
Cynthia Evans, PhD Dr. Evans has received personal compensation for serving as an employee of Eli Lilly & Company. Dr. Evans has received stock or an ownership interest from Eli Lilly & Company.
Sandrine Louchart de la Chapelle, PhD,MD Dr. LOUCHART de la CHAPELLE has nothing to disclose.
Dawn A. Brooks, PhD An immediate family member of Dr. Brooks has received personal compensation for serving as an employee of Indiana Hospital Association. Dr. Brooks has received stock or an ownership interest from Eli Lilly and Company.
Paul R. Solomon, PhD Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito. Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Solomon has received publishing royalties from a publication relating to health care.
Garry Sigman, MD Dr. Sigman has nothing to disclose.
Stephen P. Klaus, MB, BCh, BAO, M.Sc Dr. Klaus has nothing to disclose.
Tom G. Travison, PhD Prof. Travison has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for New England Research Institutes.
Aracelis Torres, PhD Dr. Torres has received personal compensation for serving as an employee of Verana Health.
Yoojin Lee, Other Ms. Lee has nothing to disclose.
Ijeoma Ekeruo No disclosure on file
Wendi Huff No disclosure on file
Mohamed Khalil No disclosure on file
Samantha Masterson No disclosure on file
Susan Mitchell No disclosure on file
Murray Zucker Murray Zucker has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for MindPath Care Centers.